Xolair subcutaneous injection 150mg syringe (YJ code: 2290400G2028, standard: 1 tube of 150mg 1mL) is a Novartis Pharma medication containing Omalizumab (genetical recombination). It is used for moderate to severe persistent asthma in people aged 6 years and older, chronic spontaneous urticaria in those 12 years and older, and chronic rhinosinusitis with nasal polyps in adults.
Xolair subcutaneous injection 150mg syringe
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).